Back to 
DRIEHAUS CAPITAL MANAGEMENT LLC
DRIEHAUS CAPITAL MANAGEMENT LLC
KNSA
Showing 0 of 4 quarters
Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in KINIKSA PHARMACEUTICALS-A
As of its Q1 2024 13F, Driehaus Capital Management held 622,540 shares of KNSA (Kiniksa Pharmaceuticals), worth $12.3M. Driehaus Capital Management's 13F filings listed KNSA from Q3 2023 to Q1 2024, 3 quarterly filings. KNSA was 0.1% of Driehaus Capital Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.